Inventec says revenue up
Contract electronics maker Inventec Corp (英業達) yesterday said that revenue last month expanded by 1.08 percent year-on-year to NT$34.55 billion (US$1.15 billion) on greater shipments of commercial notebook computers and “smart” devices. That brought cumulative sales in the first five months of this year to NT$168.99 billion, up 3.36 percent from NT$163.48 billion in the same period last year, the company said. Inventec said growth momentum of its notebooks and smartphones would continue this month, while server shipments would pick up on Chinese demand.
OUC to pay NT$0.2 dividend
Shareholders of Oriental Union Chemical Corp (OUC, 東聯化學), a petrochemical arm of Far Eastern Group (遠東集團), yesterday approved a dividend of NT$0.2 per share. The producer of ethylene glycol and specialty chemicals said a production improvement at its plant in Kaohsiung’s Linyuan District (林園) and the completion of a new plant in Yangzhou, China, have boosted ethylene glycol production capacity from 300,000 tonnes to 850,000 tonnes per year and raised its competitiveness.
AUO monthly shipments rise
LCD panel maker AU Optronics Corp (AUO, 友達光電) on Wednesday said that its large-size panel shipments last month recovered to 9.15 million units, up 5.66 percent from April, while shipments of smaller panels stayed flat at 12.75 million units. Revenue last month reached NT$28.063 billion, up 4.73 percent year-on-year and 1.03 percent month-on-month, the firm said. As revenue missed market expectations, Capital Securities Corp (群益證券) yesterday revised down its second-quarter revenue forecast for the firm to NT$84.729 billion, down 4.32 percent from the first quarter.
TaiGen books China revenue
TaiGen Biopharmaceuticals Holdings Ltd (太景醫藥研發控股) on Wednesday announced that it would book revenue of 117 million yuan (US$17.22 million) as its partnership with China’s YiChang HEC ChangJiang Pharmaceutical Co Ltd (HEC, 宜昌東陽光長江藥業) reaches a milestone. TaiGen received the payment for contributing furaprevir (TG-2349), a vital component of a cocktail treatment for hepatitis C that it is developing with its Chinese partner. TaiGen said it is scheduled to book another 116 million yuan from HEC for a stake transfer this quarter.
FOOD AND BEVERAGE
TTFB reports rising sales
Tai Tong Food & Beverage Group (TTFB, 瓦城泰統集團), which operates six restaurant chains, including Thai Town Cuisine (瓦城泰式料理), on Wednesday reported sales of NT$363.28 million for last month, up 8.85 percent year-on-year and 11.4 percent month-on-month. Sales in the first five months of the year rose 6.34 percent year-on-year to NT$1.74 billion, TTFB said.
Micron head visits Taiwan
Sanjay Mehrotra, the new president and CEO of Micron Technology Inc, yesterday visited Taiwan as the first stop of his tour of Micron’s manufacturing sites after taking his new role a month ago. In a meeting with President Tsai Ing-wen (蔡英文), Mehrotra emphasized the strategic value of Taiwan within Micron’s global footprint. He also reiterated the company’s commitment to long-term investment in the nation, including the cultivation of local talent and the construction of a new back-end fab in Taichung this year.
Gogoro Inc (睿能創意) yesterday launched its first electric bicycle, the Gogoro Eeyo 1, in Taiwan, after unveiling the bike in New York in late May and in France on Tuesday. The company said it would also introduce the series in other European countries such as Germany and the Netherlands. The “Eeyo project” is the fourth of Gogoro’s eight projects that concentrate on smart transportation, which includes Gogoro’s electric scooter, battery swap system and electric scooter sharing service, company founder and chief executive officer Horace Luke (陸學森) told a media briefing in Taipei. “There are various types of city commuters. We will not
EXPERIMENTAL DRUG: While news about a COVID-19 vaccine is more eye-catching, developing a treatment would be more viable, the Senhwa boss said Senhwa Biosciences Inc (生華科) aims to raise NT$1.5 billion (US$50.57 million) by issuing 15 million new common shares in the third quarter of this year to fund the research of new drugs, including the experimental drug Silmitasertib for the treatment of COVID-19, the company said on Monday. That would be the firm’s largest fundraising effort after it raised more than NT$1.4 billion from an initial public offering on the Taipei Exchange (TPEX) in April 2017, chief financial officer Sarah Chang (張小萍) told the Taipei Times by telephone. The price of the new shares would depend on the firm’s average share price
NOT A PANACEA: Offering 5G services would not solve the problem of declining telecom incomes, chairman Sheih Chi-mau said, expecting a flat 5G telecom revenue Chunghwa Telecom Co (中華電信) yesterday became the nation’s first telecom to debut its 5G services, offering tiered tariffs that include a threshold of NT$599 and flat rates, as it aims to switch half of its subscribers to the 5G network within three years. Subscribers would have unlimited data transmission for monthly fees starting at NT$1,399 — the same flat rate as when the company launched its 4G service in 2014 — and they can subscribe to the highest-rate plan for NT$2,699 per month for faster data transmission speeds and larger bandwidth, the company said. Data transmission speeds would be within the range
STAYING AHEAD: TSMC expects its sales this year to grow 14 to 19 percent and could spend up to US$3.52 billion on research and development, leaving its rivals far behind Taiwan Semiconductor Manufacturing Co (TSMC, 台積電) reported that the US last year approved 99 percent of its patent applications, which placed the tech giant among the top patent holders in the US. In its Corporate Social Responsibility Report, TSMC said it last year secured about 3,600 patents worldwide, including more than 2,300 in the US. As of the end of last year, TSMC owned more than 39,000 patents, the report said. The company last year filed almost 6,500 patent applications worldwide and ranked among the top 10 patent applicants in the US. In Taiwan, it was the largest patent applicant for the fourth